Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03751007
Brief Title: A Study to Assess the Safety and Tolerability of Different Doses of AG019 Administered Alone or in Combination With Teplizumab in Participants With Recently Diagnosed Type 1 Diabetes Mellitus (T1D)

First Submitted : November 8, 2018
First Submitted that Met QC Criteria : November 20, 2018
First Posted : November 22, 2018 (Estimate)

Last Update Submitted that Met QC Criteria : June 5, 2019
Last Update Posted : June 6, 2019